Volitionrx Stock Analysis
VNRX Stock | USD 0.79 0.02 1.99% |
Volitionrx is undervalued with Real Value of 1.41 and Target Price of 3.42. The main objective of Volitionrx stock analysis is to determine its intrinsic value, which is an estimate of what Volitionrx is worth, separate from its market price. There are two main types of Volitionrx's stock analysis: fundamental analysis and technical analysis.
The Volitionrx stock is traded in the USA on NYSE MKT Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Volitionrx is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday. Volitionrx Stock trading window is adjusted to America/New York timezone.
Volitionrx |
Volitionrx Stock Analysis Notes
About 23.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.36. Volitionrx had not issued any dividends in recent years. VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. The company operates Nucleosomics a technology platform for blood test. Volitionrx operates under Diagnostics Research classification in the United States and is traded on AMEX Exchange. It employs 83 people. For more information please call the company at 646 650 1351 or visit https://www.volition.com.Volitionrx Investment Alerts
Volitionrx had very high historical volatility over the last 90 days | |
Volitionrx has some characteristics of a very speculative penny stock | |
Volitionrx has high likelihood to experience some financial distress in the next 2 years | |
The company reported the previous year's revenue of 775.3 K. Net Loss for the year was (35.32 M) with profit before overhead, payroll, taxes, and interest of 306.39 K. | |
Volitionrx currently holds about 16.42 M in cash with (18.06 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28. | |
Volitionrx has a frail financial position based on the latest SEC disclosures | |
Roughly 23.0% of the company outstanding shares are owned by insiders | |
Latest headline from gurufocus.com: VolitionRX Ltd Reports Q3 Revenue of 475,000, Missing Estimates of 0.65 Million |
Volitionrx Upcoming and Recent Events
Earnings reports are used by Volitionrx to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
20th of March 2024 Upcoming Quarterly Report | View | |
8th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
20th of March 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Volitionrx Largest EPS Surprises
Earnings surprises can significantly impact Volitionrx's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2024-08-14 | 2024-06-30 | -0.09 | -0.08 | 0.01 | 11 | ||
2021-03-22 | 2020-12-31 | -0.1 | -0.11 | -0.01 | 10 | ||
2023-11-14 | 2023-09-30 | -0.13 | -0.11 | 0.02 | 15 |
Volitionrx Thematic Classifications
In addition to having Volitionrx stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical ProductsUSA Equities from Pharmaceutical Products industry as classified by Fama & French |
Volitionrx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 75.15 M.Volitionrx Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.26) | (1.33) | |
Return On Capital Employed | 9.26 | 9.72 | |
Return On Assets | (1.26) | (1.33) | |
Return On Equity | 4.53 | 4.75 |
Management Efficiency
Volitionrx has return on total asset (ROA) of (1.0082) % which means that it has lost $1.0082 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.3006) %, meaning that it created substantial loss on money invested by shareholders. Volitionrx's management efficiency ratios could be used to measure how well Volitionrx manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Volitionrx's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to rise to 4.75 in 2024, whereas Return On Tangible Assets are likely to drop (1.33) in 2024. At this time, Volitionrx's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 22.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 3.8 M in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.12) | (0.12) | |
Tangible Book Value Per Share | (0.12) | (0.12) | |
Enterprise Value Over EBITDA | (1.06) | (1.12) | |
Price Book Value Ratio | (6.55) | (6.87) | |
Enterprise Value Multiple | (1.06) | (1.12) | |
Price Fair Value | (6.55) | (6.87) | |
Enterprise Value | 36.2 M | 68.4 M |
The strategic initiatives led by Volitionrx's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Operating Margin (17.66) | Beta 1.103 | Return On Assets (1.01) | Return On Equity (7.30) |
Technical Drivers
As of the 22nd of November, Volitionrx has the Coefficient Of Variation of 1367.55, semi deviation of 4.84, and Risk Adjusted Performance of 0.0645. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Volitionrx, as well as the relationship between them.Volitionrx Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Volitionrx middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Volitionrx. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Volitionrx Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Volitionrx insiders, such as employees or executives, is commonly permitted as long as it does not rely on Volitionrx's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Volitionrx insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Volitionrx Outstanding Bonds
Volitionrx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Volitionrx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Volitionrx bonds can be classified according to their maturity, which is the date when Volitionrx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
VW 375 13 MAY 30 Corp BondUS928668BF80 | View | |
VW 335 13 MAY 25 Corp BondUS928668BE16 | View | |
VW 475 13 NOV 28 Corp BondUS928668AU66 | View | |
VW 4625 13 NOV 25 Corp BondUS928668AT93 | View | |
VW 46 08 JUN 29 Corp BondUS928668BT84 | View | |
US928668BL58 Corp BondUS928668BL58 | View |
Volitionrx Predictive Daily Indicators
Volitionrx intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Volitionrx stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Accumulation Distribution | 4825.0 | |||
Daily Balance Of Power | (0.23) | |||
Rate Of Daily Change | 0.98 | |||
Day Median Price | 0.81 | |||
Day Typical Price | 0.8 | |||
Price Action Indicator | (0.02) | |||
Period Momentum Indicator | (0.02) |
Volitionrx Forecast Models
Volitionrx's time-series forecasting models are one of many Volitionrx's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Volitionrx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Volitionrx Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Volitionrx prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Volitionrx shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Volitionrx. By using and applying Volitionrx Stock analysis, traders can create a robust methodology for identifying Volitionrx entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (46.02) | (48.32) | |
Operating Profit Margin | (46.42) | (48.74) | |
Net Loss | (45.56) | (47.83) | |
Gross Profit Margin | (0.82) | (0.86) |
Current Volitionrx Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Volitionrx analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Volitionrx analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
3.42 | Strong Buy | 4 | Odds |
Most Volitionrx analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Volitionrx stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Volitionrx, talking to its executives and customers, or listening to Volitionrx conference calls.
Volitionrx Stock Analysis Indicators
Volitionrx stock analysis indicators help investors evaluate how Volitionrx stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Volitionrx shares will generate the highest return on investment. By understating and applying Volitionrx stock analysis, traders can identify Volitionrx position entry and exit signals to maximize returns.
Begin Period Cash Flow | 10.9 M | |
Long Term Debt | 3.6 M | |
Common Stock Shares Outstanding | 71.2 M | |
Total Stockholder Equity | -7.8 M | |
Property Plant And Equipment Net | 6.1 M | |
Cash And Short Term Investments | 20.7 M | |
Cash | 20.7 M | |
Accounts Payable | 3.2 M | |
Net Debt | -14.9 M | |
50 Day M A | 0.6794 | |
Total Current Liabilities | 31.8 M | |
Other Operating Expenses | 36.8 M | |
Non Current Assets Total | 6.1 M | |
Non Currrent Assets Other | -1.00 | |
Stock Based Compensation | 2.3 M |
Additional Tools for Volitionrx Stock Analysis
When running Volitionrx's price analysis, check to measure Volitionrx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Volitionrx is operating at the current time. Most of Volitionrx's value examination focuses on studying past and present price action to predict the probability of Volitionrx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Volitionrx's price. Additionally, you may evaluate how the addition of Volitionrx to your portfolios can decrease your overall portfolio volatility.